| Biotechnology feed | All feeds
The agency issued a statement yesterday warning about the potential problems from use of long-acting beta agonists (LABAs) drugs, including Merck (NYSE: MRK) and Novartis' (NYSE:... Motley Fool via MSN Money: Feb 19 2010 8:40PM Matching: qvar Find similar documents
swung to a profit in the fourth quarter with the results led by strength in its flagship multiple-sclerosis medication as well as the launch of generic versions of some prominent drugs.
Net income at the Jerusalem... MarketWatch: Feb 16 2010 3:12PM Matching: qvar Find similar documents
swung to a profit in the fourth quarter with the results led by strength in its flagship multiple-sclerosis medication as well as the launch of generic versions of... MarketWatch: Feb 16 2010 11:53AM Matching: qvar Find similar documents
Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.
All rights reserved. All other trademarks recognized. Copyright 1997-2009 - BioPortfolio Limited.
